Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Human vaccine responses regulated by parallel cytokine pathways.
Journal: Nature immunology
Published: November 16, 2025
Mutations of two amino acids in VP5 mediate the attenuation of human rotavirus vaccine: evidence from in vitro and in vivo studies.
Journal: Journal of virology
Published: October 08, 2025
Viroporin activity is necessary for intercellular calcium signals that contribute to viral pathogenesis.
Journal: Science advances
Published: January 17, 2025
Corrigendum to "Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine" [J. Virol. Method 332 (2025) 115079].
Journal: Journal of virological methods
Published: December 15, 2024
Development and validation of a VP7-specific EIA for determining the potency and stability of inactivated rotavirus vaccine.
Journal: Journal of virological methods
Published: September 27, 2024
Clinical outcomes of closed versus open simple ankle fractures patterns requiring soft tissue reconstruction: A prospective comparative observational study.
Journal: Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons
Published: May 20, 2024
Viroporin activity from rotavirus nonstructural protein 4 induces intercellular calcium waves that contribute to pathogenesis.
Journal: bioRxiv : the preprint server for biology
Published: May 20, 2024
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus.
Journal: Mucosal immunology
Published: May 02, 2024
Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65-85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial.
Journal: The Lancet. Infectious diseases
Published: February 27, 2024
A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses.
Journal: ACS nano
Published: February 14, 2024
Last Updated: 09/26/2026